Pipeline
Therapeutics
Early Discovery | Radiopharm. Optimisation | Non-clinical Development | Phase 1 | Phase 2 | Phase 3 | Market/Partner |
---|
SSO110SCLC |
ATT001GBM |
SSO110Solid Tumours |
ATT002**alpha/beta |
ATT003**alpha/beta |
Diagnostics
Early Discovery | Radiopharm. Optimisation | Non-clinical Development | Phase 1 | Phase 2 | Phase 3 | Market/Partner |
---|
Nephroscan®99Tc |
Partnered with GE Healthcare |
ATD-PSMA68Ga |
IP licensed to AAA/Novartis (Locametz®) |
SSO120***solid tumors |
ATD001solid tumors |
SSO120***Neuroblastoma |
*Discontinued after acquisition due to competition environment, **Programs in partnership with UCB, *** ISS (Investigator Sponsored Study)